Brown Advisory Inc. Acquires 138,859 Shares of Ingevity Corporation $NGVT

Brown Advisory Inc. raised its holdings in Ingevity Corporation (NYSE:NGVT) by 15.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,040,944 shares of the company’s stock after buying an additional 138,859 shares during the quarter. Brown Advisory Inc.’s holdings in Ingevity were worth $61,603,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. CWA Asset Management Group LLC bought a new stake in shares of Ingevity in the 4th quarter worth approximately $1,305,000. Harvey Partners LLC grew its position in shares of Ingevity by 5.1% in the 3rd quarter. Harvey Partners LLC now owns 601,000 shares of the company’s stock worth $33,169,000 after buying an additional 28,953 shares during the last quarter. Alpha Wave Global LP bought a new stake in shares of Ingevity in the 3rd quarter worth approximately $8,395,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Ingevity during the fourth quarter valued at approximately $8,083,000. Finally, Simcoe Capital Management LLC boosted its position in shares of Ingevity by 49.4% during the third quarter. Simcoe Capital Management LLC now owns 933,455 shares of the company’s stock valued at $51,517,000 after purchasing an additional 308,520 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.88% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wells Fargo & Company lifted their price target on Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Jefferies Financial Group restated a “buy” rating and issued a $82.00 price target on shares of Ingevity in a research note on Thursday, February 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Finally, BMO Capital Markets restated an “outperform” rating and set a $83.00 price target on shares of Ingevity in a research note on Monday, March 2nd. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $80.00.

Ingevity Stock Performance

NYSE:NGVT opened at $72.18 on Monday. The firm has a market capitalization of $2.51 billion, a PE ratio of -20.33 and a beta of 1.18. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. The stock has a 50-day simple moving average of $71.39 and a two-hundred day simple moving average of $67.19. Ingevity Corporation has a 52-week low of $39.74 and a 52-week high of $79.29.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. The firm had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The business’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Analysts forecast that Ingevity Corporation will post 5.05 EPS for the current year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.